Dawn Ericsson, MD, a board-certified OB/GYN, alongside a clinical team experienced in peptide and metabolic therapy
Start with lower doses to assess tolerance, gradually increasing as appropriate
Together, they orchestrate a crucial hormonal regulation known as the incretin effect
The IGF-1 axis benefits from the same pause: it drifts back toward baseline instead of sitting chronically elevated, which is the safer position given GH/IGF-1s growth-promoting signaling
This matters for dosing because beta-3 receptor sensitivity varies throughout the day and in response to nutritional status
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4